Results 61 to 70 of about 377,194 (138)

Primary prophylaxis of cervical cancer The impediments in the implementation of the vaccination with Cervarix in Republic of Moldova [PDF]

, 2012
Catedra Ginecologie și Obstetrică USMF„Nicolae Testemiţanu”Cervical cancer is one of the leading causes of cancer among women all over the world.
Gangur, Doina, Codreanu, Nadejda
core  

Antibody avidity measurements in recipients of Cervarix® vaccine following a two-dose schedule or a three-dose schedule [PDF]

, 2014
The HPV-16/18 vaccine (Cervarix®) is a prophylactic vaccine for the prevention of cervical cancer and contains recombinant virus-like particles (VLPs) assembled from the L1 major capsid proteins of human papillomavirus (HPV) strains 16 and 18. Although a
Lockman, Laurence, Giannini, Sandra L., Fochesato, Michel, Boxus, Mathieu, Thomas, Florence, Lorin, Clarisse   +5 more
core   +1 more source

Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy [PDF]

, 2020
Human papillomavirus (HPV) persistent infections are associated with cervical cancer and other HPV-related diseases and tumors. Thus, the characterization of long lasting immunity to currently available HPV vaccines is important.
Nicoli F, Telatin V., Marconi P., Barzon L., Lazzarotto T, Palù G, Gabrielli L, Gavioli R., Palu G., Caputo AA., Nicoli F., Telatin V, Barzon L, Bonazzi I., Lazzarotto T., Gavioli R, Mantelli B, Bonazzi I, Marconi P, Gallerani E., Gallerani E, Mantelli B., Gabrielli L., Caputo A.   +23 more
core   +1 more source

Acceptance of HPV Vaccination: A Systematic Review of Knowledge, Attitudes and Barriers Among Healthcare Practitioners in Low‐ and Middle‐Income Countries

BioMed Research International, Volume 2026, Issue 1, 2026.
Background Cervical cancer is one of the diseases that reflects global inequities. Vaccination against the human papillomavirus (HPV) is one of the main pillars of the World Health Organization (WHO) 2030 cervical cancer 90:70:90 elimination strategy. The role of healthcare practitioners in HPV vaccination acceptance cannot be overemphasized.
Nancy Innocentia Ebu Enyan, Mengying Zhang, Sebastian Ken-Amoah, Michelle King-Okoye, Joyce Agyeiwaa, Richard Sarfo-Walters, Dorothy Addo-Mensah, Patrick Kafui Akakpo, Dorcas Obiri-Yeboah, Lawrence Doi, Cassiano Gonçalves-de-Albuquerque   +10 more
wiley   +1 more source

PIT - Produzieren im Takt® [PDF]

, 2022
Zunehmend individuelle Kundenwünsche, schwankende Auftragsmengen und hohe Effizienzanforderungen verursachen besonders bei kleinen und mittleren Unternehmen einen hohen Aufwand.

core  

Jämförelse av antigenicitet och biverkningsprofil mellan Gardasil och Cervarix [PDF]

, 2017
Syftet var att undersöka vilket av vaccinen mot Humant papillomvirus-HPV, Gardasil eller Cervarix som är att föredra, med avseende på biverkningsprofilen, det vill säga vilket av vaccinen som är mest skonsamt för kroppen.
Geraldsson, Amanda
core   +2 more sources

Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica

International Journal of Cancer, Volume 157, Issue 12, Page 2603-2618, 15 December 2025.
What's New? Infection with human papillomavirus (HPV) is the primary cause of anal cancer, for which the majority of cases occur in women. Anal cancer screening guidelines have limited evidence to inform effective strategies for women with HIV. We designed a study that was nested within the Costa Rica HPV Vaccine Trial to understand the natural history
Cameron B. Haas, Rebeca Ocampo, Danping Liu, Michael Zúñiga, Diego Guillen, Megan A. Clarke, Loretto J. Carvajal, Allan Hildesheim, John Schussler, Mónica Sierra, Teresa M. Darragh, Joel M. Palefsky, Carolina Porras, for the Costa Rica HPV Vaccine Trial (CVT) Group, Bernal Cortés, Paula González, Rolando Herrero, Silvia E. Jiménez, Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark Sherman, Ligia A. Pinto, Troy J. Kemp, Leidos Biomedical Research, Frederick National Laboratory, Cancer Research, Mary K. Sidawy, Wim Quint, Joel M. Palefsky, Mark H. Stoler, Aimée R. Kreimer, Rolando Herrero   +36 more
wiley   +1 more source

Ϻ┘äϬϡ┘ä┘è┘ä Ï╣┘å ÏÀÏ▒┘è┘éÏ® ϬÏ╣┘ä┘è┘à Ϻ┘ä┘äÏ║Ï® Ϻ┘äÏ╣Ï▒Ï¿┘èÏ® ┘ä┘äÏúÏÀ┘üϺ┘ä [PDF]

, 2017
Ϻ┘äÏ╣Ϻ┘ä┘à Ϻ┘äϬÏ▒Ï¿┘èÏ® ┘éÏ» Ï╣Ï▒┘ü┘åϺ Ïú┘å Ϻ┘äÏÀÏ▒┘è┘éÏ® ┘äϬÏ╣┘ä┘è┘à Ϻ┘ä┘äÏ║Ï® Ϻ┘äÏ╣Ï▒Ï¿┘èÏ® ┘àϬ┘å┘êÏ╣Ï®Ïî ┘à┘å┘çϺ ÏÀÏ▒┘è┘éÏ® Ϻ┘äϻϿϺÏ┤Ï▒Ï®Ïî ÏÀÏ▒┘è┘éÏ® Ϻ┘ä┘é┘êϺÏ╣ϻϺ┘ä ϬÏ▒ϼ┘àϮϮ ÏÀÏ▒┘è┘éÏ® Ϻ┘äÏ│Ï╣Ï╣┘èÏ® Ϻ┘äÏ┤┘ü┘ê┘èÏ®Ïî ÏÀÏ▒┘è┘éÏ ...
Ï╣ϺϪÏ┤Ï®, Ï»┘è┘ü┘è
core  

Estado actual de la vacuna recombinante contra el virus del papiloma humano State of the art on human papillomavirus vaccine

Acta Médica Costarricense, 2008
La infección por el virus del papiloma humano (VPH) es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50 ...
Wendy Chan Acón, Lara Aguilar Morales, Carolina Soley, Adriano Arguedas Mohs   +3 more
doaj  

Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China

Cancer Medicine, 2018
To add the growing literature on baseline of high‐risk human papillomavirus (HR‐HPV) genotype distribution in cervical intraepithelial neoplasia (CIN) before the widespread using of HPV vaccines in Chinese mainland and to improve risk stratification of ...
Yuli Wang, Jisen Xue, Xinyue Dai, Lulu Chen, Junli Li, Yancheng Wu, Yan Hu   +6 more
doaj   +1 more source